Company: OCG
Filing Date: 2025-12-11
Form Type: 424B5
Source: 0001213900-25-120719
Chunk: 79

Company: Oriental Culture Holding LTD
Filing Date: 2025-12-11
Form: 424B5
Chunk 79
---
 we or our subsidiaries are
required to obtain such permissions or approvals in the future, it could subject us to fines, penalties, or sanctions by CSRC and significantly
limit or completely hinder our ability to offer or continue to offer our securities to investors and cause the value of our securities
to significantly decline or become worthless.

<div align='center'>15</div>

We cannot rule out
the possibility that the PRC government will institute a licensing regime or pre-approval requirement covering our business operations in China at some point
in the future. If such a licensing regime or approval requirement were introduced, we cannot assure you that we would be able to obtain
any newly required license in a timely manner, or at all, which could materially and adversely affect our business and impede our ability
to continue our operations in China.

From time to time, we
may have to resort to administrative and court proceedings to enforce our legal rights. Since PRC administrative and court authorities
have significant discretion in interpreting and implementing statutory and contractual terms, it may be more difficult to evaluate
the outcome of administrative and court proceedings and the level of legal protection we enjoy in the PRC legal system than in more developed
legal systems. Furthermore, the PRC legal system is based in part on government policies and internal rules (some of which are not published
in a timely manner or at all) that may have retroactive effect. As a result, we may not be aware of our violation of these policies and
rules until sometime after the violation. Such uncertainties, including uncertainties over the scope and effect of our contractual, property
(including intellectual property) and procedural rights, and any failure to respond to changes in the regulatory environment in China
could materially and adversely affect our business and impede our ability to continue our operations.

Litigation and negative publicity surrounding China-based companies listed in the U.S. may result in increased regulatory scrutiny of us and negatively impact the trading price of our Ordinary Shares and could have a material adverse effect upon our business, including our results of operations, financial condition, cash flows and prospects.

We believe that litigation
and negative publicity surrounding companies with operations in China that are listed in the U.S. have negatively impacted stock prices
for such companies. Various equity-based research organizations have published reports on China-based companies after examining, among
other things, their corporate governance practices, related party transactions, sales practices and financial statements that have led
to special investigations and stock suspensions on national exchanges. Any similar scrutiny of us, regardless